2024年10月1日，美国食品药品监督管理局（FDA） 将飞利浦Trilogy Evo、Trilogy EV300、Trilogy Evo O2、Trilogy Evo Universal 呼吸机的召回定为 I 级，这是最严重的级别。 飞利浦表示，此次行动涉及Trilogy Evo、Trilogy EV300、Trilogy Evo O2、Trilogy Evo Universal 呼吸机，全球约 ...

(RTTNews) - Philips Respironics, affiliated to Dutch consumer electronics giant, announced additional usage instructions for Trilogy Evo Ventilators related to use of in-line nebulizers. The company ...

Philips has been dealt another blow to its ventilator business after the US Food and Drug Administration (FDA) initiated another recall, due to a power malfunction that would cause its Trilogy EVO ...

Koninklijke Philips PHG notified its customers about a possible power malfunction in itsTrilogy Evo continuous ventilators and initiated a software update to resolve the same in March. The FDA ...

Philips Respironics recently announced a mandatory software correction and updates to its instructions for use (IFU) for the Trilogy Evo, EV300, Evo02, and Evo Universal ventilators to resolve several ...

On Tuesday, Koninklijke Philips N.V. (NYSE:PHG) issued a correction related to the Software Version used in Trilogy Evo, Trilogy EV300, Trilogy Evo O2, and Trilogy Evo Universal ventilators to resolve ...